Bahrain has approved the Pfizer COVID-19 vaccine for emergency use for children aged between 5 and 11 years, the government media office said on Tuesday.
The decision came after a study involving 3,100 children aged between 5 and 11 were administered with the vaccine found it to be 90.7 per cent effecting in that age group, said the statement, citing the National Health Regulatory Authority.
None of the children involved in the study showed severe side effects, it added.
Bahrain will be supplied with doses from the manufacturer for the 5-11 age group from the start of 2022, it said.
FBI foils "terror plot" targeting Los Angeles
Hong Kong court finds tycoon Jimmy Lai guilty in landmark security trial
Ukraine peace talks stretch into second day at start of pivotal week for Europe
Flash floods kill at least 37 people in Morocco's Safi province
'Hero' who disarmed Bondi gunman recovering after surgery, family says
School bus accident in Colombia kills 17, injures 20
Australia plans tougher gun laws after father and son kill 15 at Bondi Beach
Police to release man detained over Brown University mass shooting
